L-BMAA hydrochloride

Pricing Availability   Qty
说明: Neurotoxic amino acid
化学名: 3-(Methylamino)-L-alanine hydrochloride
说明书
引用文献
评论
文献 (3)

生物活性 for L-BMAA hydrochloride

L-BMAA hydrochloride is a neurotoxic glutamate agonist originally isolated from Cycas circinalis. Implicated in the pathogenesis of amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam (Guam ALS-PD).

技术数据 for L-BMAA hydrochloride

分子量 154.6
公式 C4H10N2O2.HCl
储存 Store at -20°C
CAS Number 16012-55-8
PubChem ID 51358333
InChI Key VDXYGASOGLSIDM-DFWYDOINSA-N
Smiles N[C@@H](CNC)C(O)=O.Cl

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for L-BMAA hydrochloride

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 9.28 60

制备储备液 for L-BMAA hydrochloride

以下数据基于产品分子量 154.6。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
0.6 mM 10.78 mL 53.9 mL 107.81 mL
3 mM 2.16 mL 10.78 mL 21.56 mL
6 mM 1.08 mL 5.39 mL 10.78 mL
30 mM 0.22 mL 1.08 mL 2.16 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for L-BMAA hydrochloride

参考文献 for L-BMAA hydrochloride

参考文献是支持产品生物活性的出版物。

Weiss et al (1989) Neurotoxicity of β-N-methylamino-L-alanine (BMAA) and β-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res. 497 64 PMID: 2551452

Vega et al (1968) The preparation of L- and D-α-amino-β<-methylaminopropionic acids and the identification of the compound isolated from Cycas circinalis as the L-isomer. Phytochemistry 7 1885


If you know of a relevant reference for L-BMAA hydrochloride, please let us know.

关键词: L-BMAA hydrochloride, L-BMAA hydrochloride supplier, Neurotoxic, amino, acid, Glutamate, mGlur, Receptors, Metabotropic, iGluR, Ionotropic, Miscellaneous, 2538, Tocris Bioscience

篇 L-BMAA hydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 L-BMAA hydrochloride 的引用文献。 您是否知道使用了 Tocris L-BMAA hydrochloride 的优秀论文? 请告知我们.

L-BMAA hydrochloride 的评论

目前没有该产品的评论。 Be the first to review L-BMAA hydrochloride and earn rewards!

Have you used L-BMAA hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.